Accenture makes strategic investment in Earli

by
Contributor since / Followers

1 month ago

Accenture (NYSE:ACN) said it has made a strategic investment in Earli.
Earli is a biotechnology company that developed a novel approach to early cancer detection.
The investment will support expanding collaborations with global health and pharma companies that can use Earli’s technology to more rapidly and accurately detect and treat cancer.
Terms of the investment were not disclosed.

Tags: ACN